Bevacizumab increases late toxicity in re-irradiation with image-guided high-dose-rate brachytherapy for gynecologic malignancies-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Bevacizumab increases late toxicity in re-irradiation with image-guided high-dose-rate brachytherapy for gynecologic malignancies

Published:2022 Issue:1 Volume:14 Page:52-59
ISSN:1689-832X
Container-title:Journal of Contemporary Brachytherapy
language:
Short-container-title:jcb

Author:

Murakami Naoya,Okuma Kae,Okamoto Hiroyuki,Nakamura Satoshi,Kashihara Tairo,Kaneda Tomoya,Takahashi Kana,Inaba Koji,Igaki Hiroshi,Masui Koji,Yoshida Ken,Kato Tomoyasu,Itami Jun

Publisher

Termedia Sp. z.o.o.

Subject

Radiology, Nuclear Medicine and imaging,Oncology

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Reirradiation for recurrent gynecologic cancer using high-dose-rate brachytherapy in Japan: A multicenter survey on practice patterns and outcomes;Radiotherapy and Oncology;2024-06

2. Is it time to modify the Japanese Uterine Cervical Cancer Guidelines to recommend a higher dose for radio-resistant tumors?;Japanese Journal of Clinical Oncology;2022-11-14

3. Salvage (Re)radiation in Oligometastatic and Oligorecurrent Cervical Cancer;International Journal of Radiation Oncology*Biology*Physics;2022-11

4. Salvage image-guided freehand interstitial brachytherapy for pelvic sidewall recurrence after hysterectomy for uterine malignancies;Brachytherapy;2022-09

5. Bevacizumab;Reactions Weekly;2022-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP